Actively Recruiting
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial
Led by Sherief Abd-Elsalam · Updated on 2020-08-05
100
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the effectiveness of Nucleo CMP Forte in children with moderate to severe traumatic brain injury. The study is a randomized controlled trial designed to assess whether this treatment can improve outcomes in pediatric brain injury patients. Participants are divided into two groups: one group receives Nucleo CMP Forte twice daily for 6 weeks along with supportive treatment, while the other group receives supportive treatment alone. This comparison will help determine the potential benefits of adding Nucleo CMP Forte to standard care. Children taking part in the trial will be monitored over a period of two months to assess improvements in their Glasgow Coma Score, which measures their level of consciousness after brain injury. Researchers will evaluate how many patients show improvement, with ongoing safety and health assessments throughout the study period.
CONDITIONS
Brief Title
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with moderate or severe traumatic brain injury
You will not qualify if you...
- Presence of underlying central nervous system (CNS) disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 weeks
Participants receive Nucleo CMP Forte twice daily for 6 weeks along with supportive treatment or supportive treatment only.
Twice daily dosing for 6 weeks
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Tanta, Egypt
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here